- Published at
- by gurufocus.com
neutral
neutral
Virpax Looking to Use MET to Develop Intranasal COVID Vaccine
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (”Virpax” or the ”Company”), a company specializing in developing non-addictive products for pain managemen